ISSN: 1859 - 2872
The initial results of radiofrequency ablation for treating lung metastasis under computed tomography and Maxio robot guidance
Main Article Content
Keywords
Abstract
Objective: To evaluate the response to lung metastasis lesions treated with radiofrequency ablation and record complications of the above technique. Subject and method: A prospective and retrospective descriptive study of 25 patients with radiofrequency ablation of lung metastases under the guidance of computed tomography and Maxio robot from June 2018 to December 2023 at the 108 Military Central Hospital. Result: Mean age was 45.5 ± 8.7 years. The average tumor diameter was 25 ± 4.5mm. 23/25 patients were able to control the disease, the tumor necrosis after 6 months, 14/25 cases required a second additional burn, 01 case of life-threatening massive hemoptysis. Conclusion: Radiofrequency ablation of lung metastases under the guidance of computed tomography and Maxio robot has good initial results, with few complications
Article Details
References
2. Ketchedjian A, Daly B, Luketich J, Fernando HC (2006) Minimally invasive techniques for managing pulmonary metastases: Video-assisted thoracic surgery and radiofrequency ablation. Thorac Surg Clin 16: 157-165.
2. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H (2000) Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 174: 57-59.
3. Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: Challenges and opportunities-part II. J Vasc Interv Radiol 12: 1135-1148.
4. Pereira PL, Masala S (2012) Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors. Cardiovasc Intervent Radiol 35: 247-254.
5. Hiraki T, Mimura H, Gobara H et al (2008) Repeat radiofrequency ablation for local progression of lung tumors: Does it have a role in local tumor control? J Vasc Interv Radiol 19: 706-711.
6. Tatli S, Tapan U, Morrison PR, Silverman SG (2012) Radiofrequency ablation: Technique and clinical applications. Diagn Interv Radiol 18: 508-516.
7. Hiraki T, Gobara H, Iguchi T, Fujiwara H, Matsui Y, Kanazawa S (2014) Radiofrequency ablation for early-stage nonsmall cell lung cancer. Biomed Res Int 2014:152087. doi: 10.1155/2014/152087.
8. Crabtree T, Puri V, Timmerman R et al (2013) Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg 145: 692-699.
9. de Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiére J (2015) Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Annals of Oncology 26: 987-991. doi:10.1093/annonc/mdv037.
10. Nomura M, Yamakado K, Nomoto Y, Nakatsuka A, Ii N, Takaki H, Yamashita Y, Takeda K (2008) Complications after lung radiofrequency ablation: Risk factors for lung inflammation. Br J Radiol 81(963): 244-249.
11. Sano Y, Kanazawa S, Gobara H, Mukai T, Hiraki T, Hase S, Toyooka S, Aoe M, Date H (2007) Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: A large single-center experience. Cancer 109(7): 1397-405.
Article Sidebar
